title: Potentiators for cystic fibrosis - targeting the underlying molecular defect.
authors.affiliation: Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
authors.forename: Sanjay
authors.initials: S
authors.lastname: Patel
authors.affiliation: Department of Women's and Children's Health, University of Liverpool, Liverpool, UK. Electronic address: iansinha@liverpool.ac.uk.
authors.forename: Ian P
authors.initials: IP
authors.lastname: Sinha
authors.affiliation: Department of Biostatistics, University of Liverpool, Liverpool, UK. Electronic address: kdwan@liverpool.ac.uk.
authors.forename: Kerry
authors.initials: K
authors.lastname: Dwan
authors.affiliation: Institute of Cellular Medicine, Newcastle University, Newcastle, UK. Electronic address: carlosechevarria@doctors.org.uk.
authors.forename: Carlos
authors.initials: C
authors.lastname: Echevarria
authors.affiliation: Division of Pulmonary Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. Electronic address: mschechter@vcu.edu.
authors.forename: Michael
authors.initials: M
authors.lastname: Schechter
authors.affiliation: Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
authors.forename: Kevin W
authors.initials: KW
authors.lastname: Southern
mesh_terms: D000328:Adult; D000627:Aminophenols / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D065101:Chloride Channel Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D006801:Humans; D009154:Mutation; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012129:Respiratory Function Tests
chemical_list: D000627:Aminophenols; D065101:Chloride Channel Agonists; D015363:Quinolones; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor